Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Janet Lo, M.D.

Co-Author

This page shows the publications co-authored by Janet Lo and Sara Looby.
Connection Strength

2.211
  1. Pro-Inflammatory Interleukin-18 is Associated with Hepatic Steatosis and Elevated Liver Enzymes in People with HIV Monoinfection. AIDS Res Hum Retroviruses. 2021 05; 37(5):385-390.
    View in: PubMed
    Score: 0.235
  2. Measures of Adipose Tissue Redistribution and Atherosclerotic Coronary Plaque in HIV. Obesity (Silver Spring). 2020 04; 28(4):749-755.
    View in: PubMed
    Score: 0.221
  3. Anti-Inflammatory Interleukin 10 Inversely Relates to Coronary Atherosclerosis in Persons With Human Immunodeficiency Virus. J Infect Dis. 2020 02 03; 221(4):510-515.
    View in: PubMed
    Score: 0.220
  4. Low vitamin D is associated with coronary atherosclerosis in women with HIV. Antivir Ther. 2019; 24(7):505-512.
    View in: PubMed
    Score: 0.204
  5. I-FABP Is Higher in People With Chronic HIV Than Elite Controllers, Related to Sugar and Fatty Acid Intake and Inversely Related to Body Fat in People With HIV. Open Forum Infect Dis. 2018 Nov; 5(11):ofy288.
    View in: PubMed
    Score: 0.202
  6. Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV. J Acquir Immune Defic Syndr. 2018 05 01; 78(1):105-110.
    View in: PubMed
    Score: 0.195
  7. Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV. AIDS. 2016 Feb 20; 30(4):583-90.
    View in: PubMed
    Score: 0.167
  8. Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV. AIDS. 2016 Jan 28; 30(3):383-93.
    View in: PubMed
    Score: 0.167
  9. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. Lancet HIV. 2015 Feb; 2(2):e52-63.
    View in: PubMed
    Score: 0.155
  10. Increased aldosterone among HIV-infected women with visceral fat accumulation. AIDS. 2009 Nov 13; 23(17):2366-70.
    View in: PubMed
    Score: 0.108
  11. Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV. Nutr Diabetes. 2019 02 25; 9(1):6.
    View in: PubMed
    Score: 0.052
  12. Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV. AIDS. 2019 02 01; 33(2):229-236.
    View in: PubMed
    Score: 0.051
  13. Sex Differences in Subclinical Coronary Atherosclerotic Plaque Among Individuals With HIV on Antiretroviral Therapy. . 2018 08 01; 78(4):421-428.
    View in: PubMed
    Score: 0.050
  14. Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort. Antivir Ther. 2018; 23(4):307-314.
    View in: PubMed
    Score: 0.048
  15. Epicardial adipose tissue volume and cardiovascular risk indices among asymptomatic women with and without HIV. Antivir Ther. 2018; 23(1):1-9.
    View in: PubMed
    Score: 0.048
  16. Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus. Open Forum Infect Dis. 2017; 4(2):ofx083.
    View in: PubMed
    Score: 0.045
  17. Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals. AIDS. 2016 09 10; 30(14):2205-14.
    View in: PubMed
    Score: 0.043
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.